NCT00040040

Brief Summary

The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Jun 2002

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2002

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

June 18, 2002

Completed
Same day until next milestone

First Posted

Study publicly available on registry

June 18, 2002

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2003

Completed
Last Updated

January 11, 2017

Status Verified

August 1, 2003

First QC Date

June 18, 2002

Last Update Submit

January 10, 2017

Conditions

Amphetamine-Related Disorders

Outcome Measures

Primary Outcomes (2)

  • Psychological effects

  • BP, HR

Interventions

BupropionDRUG

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Please contact site director for more details.

You may not qualify if:

  • Please contact site director for more details.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UCLA Integrated Substance Abuse Program

Los Angeles, California, 90024, United States

Location

University of Texas Health Science Center

Houston, Texas, 77225, United States

Location

MeSH Terms

Conditions

Amphetamine-Related Disorders

Interventions

Bupropion

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PropiophenonesKetonesOrganic Chemicals

Study Officials

  • Thomas Newton, M.D.

    National Institute on Drug Abuse (NIDA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
DIAGNOSTIC
Sponsor Type
NIH

Study Record Dates

First Submitted

June 18, 2002

First Posted

June 18, 2002

Study Start

June 1, 2002

Study Completion

September 1, 2003

Last Updated

January 11, 2017

Record last verified: 2003-08

Locations

US(2)